Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($951.9M) | $1,460.5M | ($177.2M) | $176.0M | $4,535.9M | $2,164.5M | $199.5M | $89.9M | ($153.0M) | ($184.4M) | $3,213.7M | $3,527.1M | $4,266.6M | $5,649.5M | $2,889.7M | $13.5B | $12.9B | $13.0B | $14.0B | $22.3B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Eli Lilly and Company's last 12-month Net Debt is $27.6B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Eli Lilly and Company's Net Debt growth was 56.2%. The average annual Net Debt growth rates for Eli Lilly and Company have been 28.0% over the past three years, 14.4% over the past five years.
Over the last year, Eli Lilly and Company's Net Debt growth was 56.2%, which is higher than industry growth of 0.3%. It indicates that Eli Lilly and Company's Net Debt growth is Bad.